Literature DB >> 17459895

Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients.

A Campo1, G Frühbeck, J J Zulueta, J Iriarte, L M Seijo, A B Alcaide, J B Galdiz, J Salvador.   

Abstract

Leptin is a powerful stimulant of ventilation in rodents. In humans, resistance to leptin has been consistently associated with obesity. Raised leptin levels have been reported in subjects with sleep apnoea or obesity-hypoventilation syndrome. The aim of the present study was to assess, by multivariate analysis, the possible association between respiratory centre impairment and levels of serum leptin. In total, 364 obese subjects (body mass index >or=30 kg.m(-2)) underwent the following tests: sleep studies, respiratory function tests, baseline and hypercapnic response (mouth occlusion pressure (P(0.1)), minute ventilation), fasting leptin levels, body composition and anthropometric measures. Subjects with airways obstruction on spirometry were excluded. Out of the 346 subjects undergoing testing, 245 were included in the current analysis. Lung volumes, age, log leptin levels, end-tidal carbon dioxide tension, percentage body fat and minimal nocturnal saturation were predictors for baseline P(0.1). The hypercapnic response test was performed by 186 subjects; log leptin levels were predictors for hypercapnic response in males, but not in females. Hyperleptinaemia is associated with a reduction in respiratory drive and hypercapnic response, irrespective of the amount of body fat. These data suggest the extension of leptin resistance to the respiratory centre.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459895     DOI: 10.1183/09031936.00115006

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  32 in total

Review 1.  Control of respiratory and cardiovascular functions by leptin.

Authors:  M Bassi; W I Furuya; D B Zoccal; J V Menani; E Colombari; J E Hall; A A da Silva; J M do Carmo; D S A Colombari
Journal:  Life Sci       Date:  2015-01-30       Impact factor: 5.037

Review 2.  Epidemiological aspects of obstructive sleep apnea.

Authors:  John F Garvey; Martino F Pengo; Panagis Drakatos; Brian D Kent
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

3.  CrossTalk proposal: Metabolic syndrome causes sleep apnoea.

Authors:  Alexandros N Vgontzas; Jordan Gaines; Silke Ryan; Walter T McNicholas
Journal:  J Physiol       Date:  2016-06-30       Impact factor: 5.182

Review 4.  Effects of continuous positive airway pressure on energy balance regulation: a systematic review.

Authors:  Ari Shechter
Journal:  Eur Respir J       Date:  2016-10-20       Impact factor: 16.671

5.  Effects of leptin and obesity on the upper airway function.

Authors:  Mikhael Polotsky; Ahmed S Elsayed-Ahmed; Luis Pichard; Christopher C Harris; Philip L Smith; Hartmut Schneider; Jason P Kirkness; Vsevolod Polotsky; Alan R Schwartz
Journal:  J Appl Physiol (1985)       Date:  2012-02-16

6.  Peripheral mononuclear blood cells contribute to the obesity-associated inflammatory state independently of glycemic status: involvement of the novel proinflammatory adipokines chemerin, chitinase-3-like protein 1, lipocalin-2 and osteopontin.

Authors:  Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Beatriz Ramírez; Víctor Valentí; Rafael Moncada; Camilo Silva; Javier Salvador; Gema Frühbeck
Journal:  Genes Nutr       Date:  2015-04-14       Impact factor: 5.523

7.  Obesity hypoventilation syndrome.

Authors:  Laila Al Dabal; Ahmed S Bahammam
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

Review 8.  Clinical consequences of altered chemoreflex control.

Authors:  Maria Plataki; Scott A Sands; Atul Malhotra
Journal:  Respir Physiol Neurobiol       Date:  2013-05-13       Impact factor: 1.931

9.  Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome.

Authors:  Jean-Christian Borel; Pascale Roux-Lombard; Renaud Tamisier; Claire Arnaud; Denis Monneret; Nathalie Arnol; Jean-Philippe Baguet; Patrick Levy; Jean-Louis Pepin
Journal:  PLoS One       Date:  2009-08-24       Impact factor: 3.240

10.  Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity.

Authors:  José Manuel Fernández-Real; Sergio Valdés; Melania Manco; Berta Chico; Patricia Botas; Arantza Campo; Roser Casamitjana; Elías Delgado; Javier Salvador; Gema Fruhbeck; Geltrude Mingrone; Wifredo Ricart
Journal:  Diabetes Care       Date:  2010-01-19       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.